Strongyloidiasis — The Worm That Never Leaves

It's been 40 years since your patient worked on a farm in rural Southeast Asia. They feel fine. You're about to start them on prednisolone. Should you pause?

In this episode of Synapse Clinical, we unpack Strongyloides stercoralis — the soil-transmitted worm with a unique trick: it can complete its entire life cycle inside the human host, persisting silently for decades, then turning lethal the moment immunity drops.

We cover everything a GP needs to know: who to screen and when, how to recognise the clinical spectrum from mild eosinophilia to the pathognomonic larva currens rash, why eosinophilia disappears in the most dangerous presentations, and how to navigate treatment using current Therapeutic Guidelines — including the critical pre-immunosuppression checklist.

This one's for every GP who has ever written a steroid script without thinking about worms. After this episode, you will.

Strongyloidiasis. Don't look, and you won't find it.

AI-generated voices. For education and entertainment only — not for clinical decision-making or patient management.

Transcript

SPEAKER_00 0:00

Picture this. You're sitting in your consult room. It's uh it's been a really long morning, the waiting room is packed, and you've got an immunosuppressed patient sitting right across from you.

SPEAKER_01 0:08

Right. A classic busy GP morning.

SPEAKER_00 0:10

Exactly. So let's say they're originally from Vietnam, moved here decades ago, and you are just about to start them on methotrexate.

SPEAKER_01 0:18

Oh, okay.

SPEAKER_00 0:19

It feels like a totally standard routine rheumatology or dermatology prescription. But you know, you're doing your due diligence so you check their baseline bloods, and you notice a mild eosinophilia.

SPEAKER_01 0:32

Hmm. Just mild.

SPEAKER_00 0:33

Yeah, nothing crazy, just slightly elevated. The pen is in your hand, hovering over the prescription pad. Why should you pause that pen before writing the script?

SPEAKER_01 0:42

Well, because pausing that pen could literally be the difference between uh a routine follow-up in a month and a catastrophic, completely fatal hospital admission by next week.

SPEAKER_00 0:52

Aaron Powell Which is wild. And that's exactly the tension we're tackling today in this synapse clinical deep dive. We are zeroing in on a very specific, incredibly dangerous hidden passenger, which is Strongoloid Stricheralis.

SPEAKER_01 1:05

Yes, the worm that just never leaves.

SPEAKER_00 1:07

Right. Our mission today is to figure out why this specific soil-transmitted round worm matters so much in general practice, and how missing it before initiating immunosuppressants can accidentally set off well, a ticking time bomb, basically.

SPEAKER_01 1:23

Aaron Powell It's a huge responsibility for a GP, mostly because this helminth operates unlike almost anything else we treat.

SPEAKER_00 1:29

How so?

SPEAKER_01 1:30

Well, most worms follow a pretty standard script, you know? You get exposed, the worms live out their natural lifespan in your gut, and eventually, assuming you aren't re-exposed, the infection just kind of burns out.

SPEAKER_00 1:40

Right. They just die off.

SPEAKER_01 1:41

Exactly. But strangalides doesn't do that. It has this terrifying ability to lie dormant and totally asymptomatic inside a human being for decades.

SPEAKER_00 1:50

Okay, let's unpack this. How does it actually get in? And more importantly, why doesn't it ever leave? Because the pathophysiology here sounds honestly like something out of a sci-fi horror movie.

SPEAKER_01 2:01

It really does. So we're talking about larva penetrating completely intact human skin. Usually this is just someone walking barefooted on contaminated soil.

SPEAKER_00 2:09

It's a casual walk.

SPEAKER_01 2:10

Yeah. And from the moment they breach the skin, they hitch a ride via the bloodstream and the lymphatics all the way up to the lungs. Okay. They ascend the tracheobronchial tree, the patient unknowingly swallows them, and they finally drop down into the gut. And there they mature into adult female worms embedded right in the mucosa of the duodenum and the jejunum.

SPEAKER_00 2:31

And here's the crazy part. Those female worms reproduce via parthenogenesis. Yeah. Like they don't even need male worms to reproduce. No, not at all. They just start producing a specific type of offspring right there in the gut lining. The uh rhabitiform larvae. Now, let me just make sure I have my terminology straight here. Rabidiform just means the non-infective feeding stage of the worm, right? Correct. Like the grazers. And usually with other worms, these grazers are just pass out in the stool to hit the soil and continue the free living cycle outside the body. But with strongaloids, the script flips entirely.

SPEAKER_01 3:04

It does. This is where the autoinfection cycle begins. And this is the exact mechanism that separates it from almost every other soil-transmitted helmth. Those feeding rhabditiform larvae can actually transform into filleriform larva, which is the infective penetrating stage inside the GI tract.

SPEAKER_00 3:21

So they don't even need to leave the body.

SPEAKER_01 3:23

Exactly. They don't need to hit the soil to mature at all. They act like microscopic needles, just penetrating the intestinal mucosa directly, or sometimes the perianal skin, and they just start the whole migration cycle to the lungs and back to the gut all over again.

SPEAKER_00 3:36

Oh, entirely inside the human host. Yep. I've always thought of it like um like a computer program stuck in a boot loop. An error where the output of the process, the new larvae, accidentally becomes the input for the exact same process without ever leaving the system. They just keep cycling and multiplying.

SPEAKER_01 3:54

That is a perfect way to visualize it. And look, in a patient with a healthy, intact immune system, this boot loop is kept tightly in check by their TH2 immune response.

SPEAKER_00 4:03

Right. The body fights back.

SPEAKER_01 4:04

Right. The cell-mediated immunity, specifically utilizing eosinophils as like the cellular bouncers, throws a net over the whole process. It doesn't actually clear the parasite, but it suppresses the numbers.

SPEAKER_00 4:15

It just smolders.

SPEAKER_01 4:17

Exactly. Just smolders along as a low-level chronic infection.

SPEAKER_00 4:21

Aaron Powell But the moment we alter that immune system like with our hypothetical Vietnamese patients starting methotrexat, we're basically firing those bouncers.

SPEAKER_01 4:30

We are.

SPEAKER_00 4:30

The TH2 net just vanishes.

SPEAKER_01 4:32

Aaron Powell We'll get into the actual mechanics of that disaster scenario in a moment. But first, I think we need to establish who actually has this boot loop running in the background. Like for GPs in Australia, who needs to be on your radar?

SPEAKER_00 4:46

Aaron Powell It's a much broader net than you might intuitively think, right? We're looking out for people from tropical and subtropical regions globally, because that's where the soil is endemic. I think there are, what, an estimated 100 million people infected worldwide. At least in the Australian clinical context, we're talking about Aboriginal and tourist Strait Islander communities in tropical Australia, refugees, migrants, older Southern European immigrants, return travelers, and military veterans. If they've had skin contact with soil in those regions at any point in their lives, they're at risk.

SPEAKER_01 5:17

Aaron Powell Which brings us right back to our patient waiting for their script. What's fascinating here is that strongloids is the only common helm that can kill a person decades after they've left the endemic area.

SPEAKER_00 5:28

Decades.

SPEAKER_01 5:28

Yeah. Your patient could have moved from Vietnam 40 years ago, never left suburban Melbourne since, and still be harboring a dormant infection.

SPEAKER_00 5:36

Aaron Powell So if we can't rely on recent travel history, how are we supposed to spot this in a standard 15-minute consult? Because I mean the acute phase, the rash where the worm entered, a dry cough a week later, maybe some vague GI symptoms at week three, that's almost never recognized clinically.

SPEAKER_01 5:54

Aaron Powell No, almost never. Patients almost always present in the chronic phase, assuming they present at all. I mean, the vast majority are completely asymptomatic. Right. And if they do have symptoms, they're incredibly nonspecific. We're talking uh periambilical or epigastric pain, diarrhea, constipation, bloating, nausea, borborigmy.

SPEAKER_00 6:14

Borborygmy, just being the fancy clinical term for a loud, gurgling, rumbling stomach. Honestly, that symptom list sounds like every second patient who comes in complaining of irritable bowel syndrome.

SPEAKER_01 6:24

It really does. It's an absolute diagnostic nightmare based on symptoms alone. But there are a few physical clues. About two-thirds of chronic cases will have that mild eosenophilia you noticed on the baseline bloods.

SPEAKER_00 6:38

Okay, so that's a flag.

SPEAKER_01 6:39

A big one. And then there are the skin manifestations. Erticaria is quite frequent. But the real giveaway, if you're lucky enough to catch it, is larva currents.

SPEAKER_00 6:47

Larva currents. The running larva. This is considered a pathognomonic skin finding, meaning if you see it, it's definitively strong alloidins, no questions asked.

SPEAKER_01 6:57

Exactly.

SPEAKER_00 6:58

It's this intensely itchy urticareal streak, usually on the trunk, thighs, or buttocks. And when we say running, we aren't exaggerating, right? These phaleriform larvae migrate through the skin at a staggering rate of one centimeter every five minutes.

SPEAKER_01 7:12

Yeah, you can literally take a history, look back down at the patient's abdomen, and watch the rash extend in real time.

SPEAKER_00 7:18

That is just wild.

SPEAKER_01 7:20

It is. And if you see a rash moving that fast, you don't need to entertain any other differential. Unfortunately, while it's a brilliant clinical sign, it's actually quite rare to catch it in action.

SPEAKER_00 7:28

Right. So we have this spectrum from a completely silent infection to a racing rash. But we have to talk about the terrifying end of the spectrum. Hyperinfection and disseminated disease. Yeah. This is what happens when those TH2 immune system breaks fail. Yes. And usually we are the ones cutting the brake lines by prescribing corticosteroids or other immunosuppressants.

SPEAKER_01 7:48

Hyperinfection is the nightmare scenario. Without the immune system keeping it in check, that autoinfection boot loop just wildly accelerates. You get a massive, explosive increase in the larval burden within the gut, lungs, and skin.

SPEAKER_00 8:03

And the symptoms just ramp up.

SPEAKER_01 8:05

Oh, dramatically. The GI symptoms become severe watery diarrhea, profound weight loss, even bowel obstruction or perforation. In the lungs, you see dyspnea, hemoptosis, and acute respiratory distress syndrome.

SPEAKER_00 8:18

And it doesn't stop there. Disseminated disease is when these massive waves of larvae spread beyond their usual lung-to-gut route. They end up in the liver, the kidneys, the heart, the central nervous system. It may go everywhere. But it's not just the sheer volume of worms doing the damage here. There's a massive mechanical hitchhiker problem, right?

SPEAKER_01 8:35

Yes. Worse than the worms themselves are the passengers they bring. As these thousands of larva physically bore through the bowel wall to disseminate into the bloodstream, they drag enteric gram-negative bacteria right along with them. Oh wow. They literally open a highway from the gut lumen directly into the systemic circulation. This leads to secondary gram-negative bacteremia, sepsis, meningitis.

SPEAKER_00 9:00

So they basically poison the patient with their own gut flora.

SPEAKER_01 9:02

Exactly. You can have a patient die of a massive overwhelming bacterial infection entirely because the worms kick the doors open. The mortality rate for hyperinfection and disseminated disease, if untreated, is 70 to 100%.

SPEAKER_00 9:16

70 to 100% mortality. Hold on, let me push back on something regarding the lab results during this phase. This is confusing. Sure. If they have thousands of worms suddenly reproducing and ripping through their tissue, shouldn't their eosinophils be absolutely off the charts? Why do the guidelines say their eosinophil count actually goes down or disappears completely during hyperinfection?

SPEAKER_01 9:38

That is such a vital exam, Pearl, and a crucial clinical trap. The eosinophilia vanishes precisely because of why the hyperinfection is happening in the first place.

SPEAKER_00 9:47

Oh, because of the drugs.

SPEAKER_01 9:48

Right. The corticosteries you gave them aggressively suppress that TH2 immune response, wiping out the ezenophils. Alternatively, the overwhelming concurrent bacterial sepsis just crashes the bone marrow's ability to respond.

SPEAKER_00 10:02

So the absence of eosinophilia in a sick immunosuppressed patient is actually a massive red flag.

SPEAKER_01 10:07

Huge. Never use the absence of eosinophils to rule out strongloids in that clinical context. In fact, if they have known hyperinfection, the sudden disappearance of eosinophilia is an adverse prognostic sign. It means their immune system has completely folded.

SPEAKER_00 10:23

Okay, so if the symptoms mimic IBS, the pathognomonic rash is rare, and the eosinophils can vanish right when the patient is sickest. How do we actually catch this thing before handing over the methyltraxate?

SPEAKER_01 10:34

Good question.

SPEAKER_00 10:35

For our Vietnamese patient, are we sending them to the bathroom with a plastic cup, or are we sending them to phlebotomy? Because my reflex as a GP is just to order a standard stool microscopy for ova and parasites.

SPEAKER_01 10:48

We need to rewrite that reflex entirely. A single stool microscopy is practically useless for strongaloids. The sensitivity is less than 50%.

SPEAKER_00 10:57

Less than 50%. Wait, why is it so terrible? We're looking for worms in the gut. Shouldn't they be in the stool?

SPEAKER_01 11:03

It comes down to the mechanics of the autoinfection cycle. The larvae are penetrating the gut wall to reinfect the host. They aren't trying to leave. So larval shedding into the feces is highly intermittent and low volume. You're trying to catch a relatively tiny number of larvae that only occasionally pass through. You'd need up to seven separate stool samples over different days just to get the sensitivity of microscopy to a coin flip level.

SPEAKER_00 11:27

And nobody is happily providing seven separate stool samples.

SPEAKER_01 11:30

No, definitely not.

SPEAKER_00 11:31

So what's the actual practical approach for a busy GP?

SPEAKER_01 11:34

Phlebotomy is your first stop. Strongloids IgG serology using an ELISA test is the preferred screening tool. It has much higher sensitivity for population screening than single stool specimens.

SPEAKER_00 11:45

Okay, so blood test first.

SPEAKER_01 11:47

Yes. You combine that serology with three fresh fecal samples for a PCR test if your local lab offers it. The PCR has a much better profile, around 72% sensitivity and 93% specificity.

SPEAKER_00 12:00

Three fresh samples for PCR plus the IgG serology. That makes sense. But it raises a practical reality. Getting stool samples takes time, and serology results aren't always instant. Are there ever scenarios where we bypass the testing, skip the weight, and just treat them empirically?

SPEAKER_01 12:17

If we connect this to the bigger picture, empiric treatment is reserved for one very specific high-stakes scenario. When you have a patient with relevant epidemiological exposure who needs prompt, urgent immunosuppression, and you simply cannot wait for the laboratory results.

SPEAKER_00 12:31

Like someone needing high-dose steroids for an acute flare of severe inflammatory bowel disease or a transplant patient, and they happen to have grown up in a tropical area.

SPEAKER_01 12:39

Precisely. If the clinical need for the immunosuppressant is immediate, you treat empirically to prevent that 70 to 100% mortality risk of hyperinfection. But otherwise, you test.

SPEAKER_00 12:51

Because serology isn't perfect either.

SPEAKER_01 12:53

Right. Cerology can have false positives from Chrysoreacting with other soil-transmitted helmets, and the IDG antibodies can stay elevated for a while, so it can't always perfectly distinguish between a past cleared infection and a current one.

SPEAKER_00 13:06

Okay, let's say the test comes back positive for our patient, or we're in that urgent scenario and we need to treat empirically. The therapeutic guidelines, the ETG, have a very clear pharmacological approach. The drug of choice is ivermectin.

SPEAKER_01 13:21

Ivermectin is highly effective. Cure rates hover around 74 to 84%, which makes it far superior to older alternatives like albendazole, but the dosing strategy changes entirely based on the patient's immune status.

SPEAKER_00 13:33

Let's start with the immunocompetent patient. Say, a return traveler who is totally asymptomatic but popped positive on a routine screening serology.

SPEAKER_01 13:42

For them, it's a weight-based dose of ivermectin, 200 micrograms per kilogram, up to a maximum of 36 milligrams. They take a single dose and then they repeat that exact same single dose one more time, seven to fourteen days later.

SPEAKER_00 13:56

So just two doses total?

SPEAKER_01 13:58

Exactly.

SPEAKER_00 13:59

Simple enough. But what about our immunocompromised patient, the one we're trying to protect from hyperinfection before starting methotrexate?

SPEAKER_01 14:06

They require the four-dose regimen. It's the same weight-based dose, but they take it daily on days one, two, fifteen, and sixteen.

SPEAKER_00 14:14

Okay, I have to ask about that oddly specific timeline. Why specifically days 15 and 16? What happens at week two? Does the drug only kill the adult worms, leaving the eggs behind?

SPEAKER_01 14:25

It's actually the reverse. Ivermectin is highly effective at paralyzing and killing the larva, but it's less effective against the adult female worms embedded in the mucosa. Ah, okay. Remember that auto-infection cycle? A full cycle from an egg hatching to a larva maturing to an adult migrating and laying new eggs takes roughly two weeks.

SPEAKER_00 14:43

Oh, so days 15 and 16 are acting as the strategic cleanup crew.

SPEAKER_01 14:47

Exactly. You're wiping out any newly maturing larvae that were just eggs or unkillable early stage parasites during the first doses, right before they can mature and lay a new generation of eggs. It ensures you completely sever the boot loop.

SPEAKER_00 15:01

That's brilliant. You're weaponizing the parasite's own life cycle against it.

SPEAKER_01 15:04

Yes.

SPEAKER_00 15:05

And what if the worst happens? And a patient is already in full-blown hyperinfection or disseminated disease.

SPEAKER_01 15:11

That's an absolute hospital emergency. They need urgent admission, infectious disease specialist input, and they'll likely be on daily ivermectin until their bodily fluids are completely clear of larva for at least two weeks.

SPEAKER_00 15:23

Wow, daily.

SPEAKER_01 15:24

Daily. But crucially, because of those bacterial hitchhikers we discussed, they also need broad spectrum intravenous antibiotics, like iV septriaxone, to treat the secondary gram-negative sepsis. And wherever clinically feasible, you must immediately reduce or cease their immunosuppressive therapy.

SPEAKER_00 15:41

It's a massive multi-system undertaking. Now, for GPs writing that standard ivermectin script in the community, there are a couple of vital prescribing pearls. First, the tablets usually come as three milligram pills. The guidelines say to round the calculated weight-based dose to the nearest half tablet, so the nearest 1.5 milligrams. Right. But there's a major safety check before you even print that script involving a totally different parasite.

SPEAKER_01 16:05

Yes, there is. If your patient is a refugee or migrant from sub-Saharan Africa regions where the Loa Loa parasite is endemic, you must screen them for Loa Loa with a blood smear before giving ivermectin.

SPEAKER_00 16:18

Wait, what's actually happening at a cellular level there? Why does treating one worm cause a crisis with another?

SPEAKER_01 16:24

Aaron Ross Powell LoA produces massive amounts of microfilaria that circulate in the blood. If a patient has a high microfilarial burden, giving them ivermectin causes a rapid, massive die-off of these parasites all at once. Uh-oh. Yeah. The sheer volume of dead and dying microfilaria can physically block the capillaries in the brain, precipitating a life-threatening encephalopathy.

SPEAKER_00 16:46

So by trying to clear a gut worm, you essentially cause a microscopic stroke cascade. That's terrifying.

SPEAKER_01 16:53

It's a rare scenario in standard Australian practice, but for patients from those specific regions, it's a critical, non-negotiable safety step.

SPEAKER_00 17:02

And there's one more prescribing pearl, arguably the most practical one to tell the patient as they leave the room. How should they physically take the tablet? Because ivermectin has some specific pharmacokinetic quarks.

SPEAKER_01 17:15

They need to take it with fatty food. Yep. Ivermectin is highly lipophilic, meaning it dissolves in fats, not water. If you take it on an empty stomach, the GI absorption is remarkably poor. Taking it with a high-fat meal significantly boosts the absorption into the bloodstream, ensuring the drug actually reaches the systemic concentrations needed to hunt down the migrating larvae.

SPEAKER_00 17:37

So take this worm medication with a cheeseburger or a heavily buttered piece of toast. That's the kind of highly actionable instruction patients actually remember. Okay, let's bring this all home and close the loop on our opening scenario. We're back with our Vietnamese patient. The pen is overing. We notice the mild eosinophilia. What's the actual safety net action plan here?

SPEAKER_01 17:59

The plan is sequential. Pause, screen, treat, and then suppress. You hold the methotrexate, you send them to phlebotomy for the stronglyloids IgG serology, and if possible, get the three fresh stool PCRs. Right. If they come back positive, you treat them with the ivermectin regimen with a cheeseburger. Once you're confident the infection is cleared, then you can safely initiate the methotrexate.

SPEAKER_00 18:23

How do we actually know they're cleared though? What does successful follow-up look like for a GP?

SPEAKER_01 18:27

Aaron Powell If you're tracking serology, you want to see falling immunoreactivity titers at three to six months post-treatment. If they had eosinophilia initially, you check their full blood count every three months, and you expect those eosinophil levels to normalize within that three-month window.

SPEAKER_00 18:41

Aaron Powell We should also mention when a GP should just pick up the phone and refer. Hyperinfection is obviously an urgent hospital admission.

SPEAKER_01 18:48

Without a doubt.

SPEAKER_00 18:49

But we should also seek expert advice for children under one-year-old, complex transplant patients, or if we need to use a special veterinary formulation of subcutaneous ivermectin, because a critically ill patient's gut just can't absorb the oral pills.

SPEAKER_01 19:04

Yes, definitely refer those. But here's the ultimate curve ball for the GP in the community. What if we test our Vietnamese patient and we treat them perfectly with the four-dose ivermectin schedule? They take it with fatty food, but at the three-month mark, their eosinophils won't budge, or their stool PCR is still positive.

SPEAKER_00 19:22

Oh, like what if the treatment just flat out fails?

SPEAKER_01 19:24

Exactly.

SPEAKER_00 19:24

Well the guidelines say if there's persistent eosinophilia beyond 12 months, evaluate for other causes. But if none are found, repeat the treatment. But if they fail two treatment courses, why would a worm suddenly become invincible to our best drugs?

SPEAKER_01 19:39

This raises an important question. It points to a very specific, dangerous underlying coinfection, HTLV1, human T lymphotropic virus type 1.

SPEAKER_00 19:48

HTLV1, wait, why does a virus make a worm so hard to clear? What's the mechanism there?

SPEAKER_01 19:53

HTLV1 fundamentally hijacks the host's immune response. It shifts the immune system heavily toward a TH1 response. And by overactivating the TH1 pathways, it aggressively suppresses the TH2 pathways.

SPEAKER_00 20:06

Which are the exact pathways responsible for producing eosinophils and fighting off helmets.

SPEAKER_01 20:11

Precisely. The virus effectively turns off the body's antiparasite defenses, making it incredibly difficult for ivermectin to clear the massive unchecked worm burden.

SPEAKER_00 20:22

So if a patient fails two courses of ivermectin, GPs must test for HTLV1 and refer them for specialist review immediately, because the entire management landscape has just changed.

SPEAKER_01 20:33

Exactly. It's the most significant risk factor for both dissemination and treatment failure.

SPEAKER_00 20:37

We've covered a massive amount of ground here today, from the auto-infecting bootloop in the gut to the racing larva currents rash on the skin to the microscopic stroke risks of Loa Loa. I always like to lock in a core takeaway. For me, it's understanding the mechanics of that four-dose regimen days one, two, fifteen, and sixteen, and realizing those last two doses are the cleanup crew timing perfectly with the two-week autoinfection cycle. That, and making absolutely sure I tell my patients to take their ivermectin with a high-fat meal. What's your top clinical pearl?

SPEAKER_01 21:08

For me, it's the fundamental respect we need to have for this parasite's lifespan. Strongloids is the only common worm that can kill a person decades after they were exposed. We can't let a remote travel history lull us into a false sense of security when we're prescribing potent immunosuppressants. A remote history is still a current risk.

SPEAKER_00 21:28

Aaron Powell I love that. And I know you wanted to leave everyone listening with a final, slightly provocative thought to mull over during their next clinic session.

SPEAKER_01 21:35

Aaron Powell I do. So we know that strongloid colitis can perfectly mimic the symptoms and even the endoscopic appearance of ulcerative colitis. And we've just discussed how high dose steroids rapidly accelerate the autoinfection cycle into fatal hyperinfection. Consider how many past cases you might have heard about. Someone with unexplained sepsis or an atypical ulcerative colitis patient who suddenly deteriorated, developed gram negative. Bacteremia went into multi-organ failure and passed away shortly after being put on high dose steroids. Oh wow. How many of those tragic, unexplained clinical deteriorations might have actually been hidden, completely preventable stronglyloids hyperinfection that simply wasn't screened for?

SPEAKER_00 22:17

That's a chilling thought, but an incredibly important diagnostic anchor to keep us sharp. Thank you all for joining us on this Synapse Clinical Deep Dive. Take these pearls, respect the latent power of this parasite, and always pause that pen before starting immunosuppressants. We'll catch you next time.